Cargando…

DNA topoisomerase IIα and -β expression in human ovarian cancer

To study DNA topoisomerase IIα (Topo-IIα) and -β expression and regulation in human ovarian cancer, 15 ovarian tumour samples were investigated. To compare different levels of expression, the samples were screened for topo IIα and -β mRNA with Northern blotting and a quantitative reverse transcripta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Withoff, S, Zee, A G J van der, Jong, S de, Hollema, H, Smit, E F, Mulder, N H, Vries, E G E de
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362692/ https://www.ncbi.nlm.nih.gov/pubmed/10070864 http://dx.doi.org/10.1038/sj.bjc.6690120

Ejemplares similares

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin
por: Jong, R S de, et al.
Publicado: (1999)

Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase II α gene transfer is independent of topoisomerase II β
por: Zhou, Z, et al.
Publicado: (2001)

Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel.
por: Withoff, S., et al.
Publicado: (1996)

Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
por: Withoff, S., et al.
Publicado: (1996)

Ovarian cysts in women receiving tamoxifen for breast cancer
por: Mourits, M J E, et al.
Publicado: (1999)

Lycobetaine acts as a selective topoisomerase IIβ poison and inhibits the growth of human tumour cells
por: Barthelmes, H U, et al.
Publicado: (2001)

Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients
por: Ferrandina, G, et al.
Publicado: (2008)

Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase IIα and IIβ
por: Fief, Cole A., et al.
Publicado: (2019)

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.
por: van der Zee, A. G., et al.
Publicado: (1992)

Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy
por: Hannemann, J, et al.
Publicado: (2006)

Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance
por: Lage, H, et al.
Publicado: (2000)

Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint
por: Kozuki, Toshiyuki, et al.
Publicado: (2017)

Dynamics of human DNA topoisomerases IIα and IIβ in living cells
por: Christensen, Morten O., et al.
Publicado: (2002)

Natural Products as Topoisomerase II Poisons: Effects of Thymoquinone on DNA Cleavage Mediated by Human Topoisomerase IIα
por: Ashley, Rachel E., et al.
Publicado: (2014)

Nuclear interactions of topoisomerase II α and β with phospholipid scramblase 1
por: Wyles, Jessica P., et al.
Publicado: (2007)

Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation
por: Schröder, C P, et al.
Publicado: (2001)

A phase I and pharmacokinetic study of intraperitoneal topotecan
por: Hofstra, L S, et al.
Publicado: (2001)

The Roles of DNA Topoisomerase IIβ in Transcription
por: Madabhushi, Ram
Publicado: (2018)

Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia
por: Michelson, Andrew P., et al.
Publicado: (2020)

The Impact of the C-Terminal Domain on the Interaction of Human DNA Topoisomerase II α and β with DNA
por: Gilroy, Kathryn L., et al.
Publicado: (2011)

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
por: de Graeff, P, et al.
Publicado: (2008)

DNA topoisomerase IIα expression and the response toprimary chemotherapy in breast cancer
por: MacGrogan, G, et al.
Publicado: (2003)

Expression of topoisomerase III α in normal and neoplastic tissues determined by immunohistochemistry using novel monoclonal antibody
por: Lodge, A J, et al.
Publicado: (2000)

Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II
por: Twelves, C J, et al.
Publicado: (1999)

Exploration of the Role of the C-Terminal Domain of Human DNA Topoisomerase IIα in Catalytic Activity
por: Dougherty, Ashley C., et al.
Publicado: (2021)

C-Terminal regions of topoisomerase IIα and IIβ determine isoform-specific functioning of the enzymes in vivo
por: Linka, René M., et al.
Publicado: (2007)

Immunochemotherapy with interleukin-2, interferon- α and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study
por: Herpen, C M L van, et al.
Publicado: (2000)

Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer.
por: Cunningham, J. M., et al.
Publicado: (1991)

A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix
por: Wit, R de, et al.
Publicado: (1999)

Survival-Related Profile, Pathways, and Transcription Factors in Ovarian Cancer
por: Crijns, Anne P. G, et al.
Publicado: (2009)

Role of Topoisomerase IIβ in DNA Damage Response following IR and Etoposide
por: Sunter, Nicola J., et al.
Publicado: (2010)

Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy.
por: Meijer, C., et al.
Publicado: (1997)

PIASy-dependent SUMOylation regulates DNA topoisomerase IIα activity
por: Ryu, Hyunju, et al.
Publicado: (2010)

Expression of DNA topoisomerase II-α: Clinical significance in laryngeal carcinoma
por: FENG, YAN, et al.
Publicado: (2014)

Catalytic Core of Human Topoisomerase IIα: Insights into Enzyme–DNA Interactions and Drug Mechanism
por: Lindsey, R. Hunter, et al.
Publicado: (2014)

αII-spectrin and βII-spectrin do not affect TGFβ1-induced myofibroblast differentiation
por: Piersma, Bram, et al.
Publicado: (2018)

Human topoisomerase IIα uses a two-metal-ion mechanism for DNA cleavage
por: Deweese, Joseph E., et al.
Publicado: (2008)

Modulation of Calcium Current in Arteriolar Smooth Muscle by α(v)β(3) and α(5)β(1) Integrin Ligands
por: Wu, Xin, et al.
Publicado: (1998)

A Molecular Mechanism of Integrin Crosstalk: α(v)β(3 )Suppression of Calcium/Calmodulin-dependent Protein Kinase II Regulates α(5)β(1) Function
por: Blystone, Scott D., et al.
Publicado: (1999)

Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β
por: Ortega, Jose Antonio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_554c6p2absk8e13gond739npkt